http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3950422-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-811 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0011 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J41-00 |
filingDate | 1974-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1976-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6526a5c7abc9fe9979de58e5b0114550 |
publicationDate | 1976-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-3950422-A |
titleOfInvention | 6-Amino-isoproterenol |
abstract | Biologically active substances having labile aryl groups can be converted to the corresponding aryl amine derivatives. The biologically active substances are reacted with a diazonium compound which optionally can be linked to a solid, inorganic carrier such as porous glass beads for ease of purification. The diazo reaction product is then reductively cleaved with a chemical reducing agent such as with hydrosulfite to yield the desired amine derivative. A preferred class of biologically active substances used herein is the catecholamines. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4556664-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4252824-A |
priorityDate | 1974-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1107.